SEELOS THERAPEUTICS, INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Seelos Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Seelos Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was 92.8 %.
  • Seelos Therapeutics, Inc. annual Return On Assets for 2023 was -321 %, a 104% decline from 2022.
  • Seelos Therapeutics, Inc. annual Return On Assets for 2022 was -158 %, a 76.7% decline from 2021.
  • Seelos Therapeutics, Inc. annual Return On Assets for 2021 was -89.2 %, a 42.4% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -321 -164 -104% Jan 1, 2023 Dec 31, 2023
2022 -158 -68.4 -76.7% Jan 1, 2022 Dec 31, 2022
2021 -89.2 +65.8 +42.4% Jan 1, 2021 Dec 31, 2021
2020 -155 +256 +62.3% Jan 1, 2020 Dec 31, 2020
2019 -411 -337 -461% Jan 1, 2019 Dec 31, 2019
2018 -73.2 -77.5 -1792% Jan 1, 2018 Dec 31, 2018
2017 4.32 +104 Jan 1, 2017 Dec 31, 2017
2016 -100 +57.1 +36.3% Jan 1, 2016 Dec 31, 2016
2015 -157 -48.1 -44.1% Jan 1, 2015 Dec 31, 2015
2014 -109 -33.1 -43.6% Jan 1, 2014 Dec 31, 2014
2013 -76 +25.1 +24.8% Jan 1, 2013 Dec 31, 2013
2012 -101 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.